The diagnostic and prognostic values of plasma Epstein-Barr virus DNA for residual cervical lymphadenopathy in nasopharyngeal carcinoma patients: a retrospective study

BACKGROUND: Currently, the diagnosis and treatment of nasopharyngeal carcinoma (NPC) patients with residual cervical lymphadenopathy following radical radiotherapy with or without chemotherapy are challenging. We investigated the prognosis of NPC patients with residual cervical lymphadenopathy and a...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Sai-Lan, Sun, Xue-Song, Li, Xiao-Yun, Tang, Lin-Quan, Chen, Qiu-Yan, Lin, Huan-Xin, Liang, Yu-Jing, Yan, Jin-Jie, Lin, Chao, Guo, Shan-Shan, Liu, Li-Ting, Li, Yang, Xie, Hao-Jun, Tang, Qing-Nan, Liang, Hu, Guo, Ling, Mai, Hai-Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6441165/
https://www.ncbi.nlm.nih.gov/pubmed/30925939
http://dx.doi.org/10.1186/s40880-019-0357-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6441165/
https://www.ncbi.nlm.nih.gov/pubmed/30925939
http://dx.doi.org/10.1186/s40880-019-0357-9

Ejemplares similares